Nanotechnology Platform for Ex Vivo Gene Therapy
Current gene transfer technologies in cell therapy manufacturing are limited by specificity, size of insert, multiplexing capabilities, time, and cost.
This project uses nano-injection to develop more efficient gene transfer technology and engineer T cells for therapeutic treatments.
Aids with identifying the nature and cause(s) of a clinical problem or illness
Increases the efficacy of a clinical process or procedure
Enables healing from or treatment of an illness or clinical problem
Records/shares data as on-going surveillance of a clinical problem, process or procedure
Patrick Lundgren, MSc
Co-Founder and Immunology Graduate Student at the Perelman School of Medicine
Professor of Mechanical Engineering and Applied Mechanics